Houston, TX, United States of America

Valerie Lebleu

This inventor holds 3 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valerie Lebleu. Retrieved from https://idiyas.com/inventor/valerie-lebleu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Valerie Lebleu: Innovator in MSC-Derived Exosome Production

Introduction

Valerie Lebleu is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of biotechnology, particularly in the production of exosomes derived from mesenchymal stem cells (MSCs). With a total of 3 patents, her work is paving the way for advancements in therapeutic applications.

Latest Patents

Valerie's latest patents focus on methods for the production of MSC-derived exosomes. These patents detail innovative techniques for manufacturing clinical-grade exosomes, which are crucial for various medical applications. Additionally, her work includes methods for loading these exosomes with therapeutic agents, such as siRNA, and outlines approaches for treating diseases through the administration of these clinical-grade exosomes.

Career Highlights

Valerie is affiliated with the University of Texas System, where she continues to advance her research in the field of stem cell technology and exosome production. Her expertise and dedication to innovation have positioned her as a key figure in her area of study.

Collaborations

Some of Valerie's notable coworkers include Elizabeth J Shpall and Raghu Kalluri, who are also recognized for their contributions to the field of stem cell research and biotechnology.

Conclusion

Valerie Lebleu's work in the production of MSC-derived exosomes represents a significant advancement in biotechnology. Her innovative methods and dedication to research are likely to have a lasting impact on the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…